The present study demonstrated that GSK-3β maintained the epithelial phenotype of BGC-823 gastric cancer cells, and PI3K/Akt-GSK-3β signaling is an upstream factor of ZEB2 activation in the IGF-I-induced EMT process. This evidence concerns the gene ZEB2 and gastric cancer.